MS Trust Shop Drugs and other treatments
Please note that items can only be posted to addresses in the UK.
The MS Trust is a UK charity, one of our main objectives is to supply information to people affected by MS. We are able to do this free of charge thanks mainly to the generosity of the UK public. In order to ensure the maximum number of people are able to receive our publications we need to limit our supplies to 1 copy per item ordered. Thank you for observing this limit. Health professionals may request larger quantities for delivery to their place of work. If you have any queries please contact us on 01462 476700 or via info@mstrust.org.uk.
Alemtuzumab (Lemtrada) - factsheet
Alemtuzumab is an experimental new drug that has shown promising results as a treatment for people with relapsing remitting MS. The factsheet discusses the recent and ongoing research into the drug and some of the safety concerns raised during trials.
Price: Free
BG-12 (Tecfidera) - factsheet
BG-12 is an experimental new drug that has shown promising results as a treatment for people with relapsing remitting MS. The factsheet discusses the recent research into the drug, side effects and current licensing status.
Price: Free
Disease modifying drug therapy
A book for people with relapsing MS, who may be considering treatment with one of the disease modifying drug therapies. It aims to provide an understanding of how the drugs work and affect MS, and help readers have informed discussions with their health team about the treatment options.
Price: Free
Fampridine (Fampyra) - factsheet
This factsheet provides information about fampridine, a drug treatment for improving walking in MS.
Price: Free
Functional electrical stimulation (FES) - factsheet
FES is a form of treatment to aid mobility and is chiefly used in MS to correct dropped foot. This factsheet looks at how the treatment works, who might benefit and how to find services.
Price: Free
Laquinimod - factsheet
Laquinimod is an experimental new drug that has shown promising results as a treatment for people with relapsing remitting MS. The factsheet discusses the recent research into the drug, side effects and current licensing status.
Price: Free
Mitoxantrone - factsheet
Mitoxantrone is a chemotherapy drug that is occasionally used to treat aggressive relapsing remitting or secondary progressive MS where relapses are still a significant feature.
Price: Free
Sativex - factsheet
Information on the cannabis based mouth spray that is licensed as an add-on treatment for spasticity.
Price: Free
Stem cells - factsheet
There has been a great deal of coverage of stem cell treatments in the press recently. To provide a wider perspective the MS Trust has produced this factsheet
Price: Free
Teriflunomide (Aubagio) - factsheet
Teriflunomide (Aubagio) is an experimental new drug that has shown promising results as a treatment for people with relapsing remitting MS. The factsheet discusses the recent research into the drug, side effects and current licensing status.
Price: Free
Vitamin D - factsheet
There is increasing interest in the role of vitamin D both as a possible trigger for multiple sclerosis and as a treatment for MS. This factsheet covers some of the recent research.
Price: Free